Guided Therapeutics (GTHP) Other Non-Current Liabilities (2013 - 2025)
Guided Therapeutics recorded quarterly Other Non-Current Liabilities of $37000.0 in Q4 2025, down 53.16% quarter-over-quarter from $79000.0 in Q3 2025, and down 68.64% year-over-year from $118000.0 in Q4 2024.
Guided Therapeutics' Other Non-Current Liabilities history runs 12 years deep, the most recent figure standing at $37000.0 for Q4 2025.
- In Q4 2025, Other Non-Current Liabilities fell 68.64% year-over-year to $37000.0; the TTM figure through Dec 2025 stood at $37000.0 (down 68.64% YoY), while the FY2025 annual figure was $37000.0, down 68.64% from the prior year.
- Other Non-Current Liabilities came in at $37000.0 for Q4 2025 at Guided Therapeutics, down from $79000.0 in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $118000.0 in Q4 2024 to a low of -$38000.0 in Q3 2021.
- A 4-year average of $29416.7 and a median of $26000.0 in 2021 frame the typical range for Other Non-Current Liabilities.
- Across the five-year window, Other Non-Current Liabilities tumbled 115.62% in 2022 and soared 361.54% in 2025, its largest moves.
- Guided Therapeutics' Other Non-Current Liabilities stood at $32000.0 in 2021, then sank by 115.62% to -$5000.0 in 2022, then surged by 2460.0% to $118000.0 in 2024, then sank by 68.64% to $37000.0 in 2025.
- According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $37000.0, $79000.0, and $60000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Guided Therapeutics | - | - | 458,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 37,000.00 |
| Sep 30, 2025 | 79,000.00 |
| Jun 30, 2025 | 60,000.00 |
| Mar 31, 2025 | 66,000.00 |
| Dec 31, 2024 | 118,000.00 |
| Sep 30, 2024 | 20,000.00 |
| Jun 30, 2024 | 13,000.00 |
| Dec 31, 2022 | -5,000.00 |
| Sep 30, 2022 | -5,000.00 |
| Jun 30, 2022 | -24,000.00 |
| Dec 31, 2021 | 32,000.00 |
| Sep 30, 2021 | -38,000.00 |
| Dec 31, 2020 | -32,000.00 |
| Sep 30, 2020 | 5.52 Mn |
| Jun 30, 2020 | 7.58 Mn |
| Mar 31, 2020 | 1.80 Mn |
| Dec 31, 2019 | 5.09 Mn |
| Sep 30, 2019 | 6.10 Mn |
| Jun 30, 2019 | 6.48 Mn |
| Mar 31, 2019 | 4.32 Mn |
| Dec 31, 2018 | 4.73 Mn |
| Sep 30, 2018 | 3.39 Mn |
| Jun 30, 2018 | 2.08 Mn |
| Mar 31, 2018 | 6.27 Mn |
| Dec 31, 2017 | 7.96 Mn |
| Sep 30, 2017 | 1.83 Mn |
| Jun 30, 2017 | 1.07 Mn |
| Mar 31, 2017 | 847,000.00 |
| Dec 31, 2016 | 1.42 Mn |
| Sep 30, 2016 | 821,000.00 |
| Jun 30, 2016 | 1.49 Mn |
| Mar 31, 2016 | 1.59 Mn |
| Dec 31, 2015 | 2.61 Mn |
| Sep 30, 2015 | 1.29 Mn |
| Jun 30, 2015 | 956,000.00 |
| Mar 31, 2015 | 262,000.00 |
| Dec 31, 2014 | 2.07 Mn |
| Sep 30, 2014 | 1.25 Mn |
| Jun 30, 2014 | 1.05 Mn |
| Mar 31, 2014 | 1.01 Mn |
| Dec 31, 2013 | 1.55 Mn |
| Sep 30, 2013 | 663,000.00 |
| Jun 30, 2013 | 873,000.00 |